Sensus Healthcare Inc
Follow $SRTS
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $SRTS by emailVeridion Score
BETALOW CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is SRTS moving today?
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
SRTS overview
Related filings and maps
Congress activity in SRTS
No receipt-qualified Congressional disclosure is present for SRTS in the cached public ledger.
SRTS contract awards, year to date.
Public federal awards linked to this ticker.
SRTS lobbying filings, year to date.
Registered lobbying filings matched to Sensus Healthcare Inc.